Titre:
  • CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Auteur:Pita, Jaime Miguel; Raspé, Eric; Coulonval, Katia; Decaussin-Petrucci, Myriam; Tarabichi, Maxime; Dom, Geneviève; Libert, Frédérick; Ruscas-Craciun, Ligia Ioana; Andry, Guy; Wicquart, Laurence; Leteurtre, Emmanuelle; Tresallet, Christophe; Marlow, Laura A; Copland, John A; Durante, Cosimo; Maenhaut, Carine; Cavaco, Branca Maria; Dumont, Jacques Emile; Costante, Giuseppe; Roger, Pierre P.
Informations sur la publication:Frontiers in endocrinology, 14, page (1247542)
Statut de publication:Publié, 2023-10-26
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:ATC
CDK4 Thr172-phosphorylation
PDTC
biomarkers
dabrafenib
palbociclib
trametinib
Langue:Anglais
Identificateurs:urn:issn:1664-2392
info:doi/10.3389/fendo.2023.1247542
info:pmid/37964967
PMC10641312